Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

PubMed Links for Books (Select 1488616)

1.

Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.

Wang CJ, Chen IP, Koczon-Jaremko B, Boskey AL, Ueki Y, Kuhn L, Reichenberger EJ.

Bone. 2010 May;46(5):1306-15. doi: 10.1016/j.bone.2010.01.380. Epub 2010 Feb 1.

2.

SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.

Hanna N, Parfait B, Talaat IM, Vidaud M, Elsedfy HH.

Clin Genet. 2009 Jun;75(6):568-71. doi: 10.1111/j.1399-0004.2009.01149.x. Epub 2009 May 5.

PMID:
19438935
3.

Familial cherubism: the experience of the Moscow Central Institute for Stomatology and Maxillo-Facial Surgery.

Roginsky VV, Ivanov AL, Ovtchinnikov IA, Khonsari RH.

Int J Oral Maxillofac Surg. 2009 Mar;38(3):218-23. doi: 10.1016/j.ijom.2008.10.010. Epub 2008 Nov 26.

PMID:
19038533
4.

Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.

Carvalho VM, Perdigão PF, Amaral FR, de Souza PE, De Marco L, Gomez RS.

Oral Dis. 2009 Jan;15(1):106-10. doi: 10.1111/j.1601-0825.2008.01499.x. Epub 2008 Nov 11.

PMID:
19017279
5.

SH3BP2 is an activator of NFAT activity and osteoclastogenesis.

Lietman SA, Yin L, Levine MA.

Biochem Biophys Res Commun. 2008 Jul 11;371(4):644-8. doi: 10.1016/j.bbrc.2008.04.080. Epub 2008 Apr 25.

6.

Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.

Ueki Y, Lin CY, Senoo M, Ebihara T, Agata N, Onji M, Saheki Y, Kawai T, Mukherjee PM, Reichenberger E, Olsen BR.

Cell. 2007 Jan 12;128(1):71-83.

7.

Neurofibromatosis presenting with a cherubism phenotype.

van Capelle CI, Hogeman PH, van der Sijs-Bos CJ, Heggelman BG, Idowu B, Slootweg PJ, Wittkampf AR, Flanagan AM.

Eur J Pediatr. 2007 Sep;166(9):905-9. Epub 2006 Nov 21.

PMID:
17120035
8.

Cherubism: long-term follow-up of 2 patients in whom it regressed without treatment.

Silva GC, Gomez RS, Vieira TC, Silva EC.

Br J Oral Maxillofac Surg. 2007 Oct;45(7):567-70. Epub 2006 Oct 6.

PMID:
17030358
9.

Brown tumor of the facial bones: case report and literature review.

Lessa MM, Sakae FA, Tsuji RK, Filho BC, Voegels RL, Butugan O.

Ear Nose Throat J. 2005 Jul;84(7):432-4. Review.

PMID:
16813033
10.

Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.

Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA.

Hum Mutat. 2006 Jul;27(7):717-8.

PMID:
16786512
11.

DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.

de Lange J, van Maarle MC, van den Akker HP, Redeker EJ.

Br J Oral Maxillofac Surg. 2007 Sep;45(6):499-500. Epub 2006 May 19.

PMID:
16713042
12.

The aggressive form of cherubism: report of two cases in unrelated families.

Wang CN, Song YL, Peng B, Lu DH, Fan MW, Li J, Ye XQ, Fan HL, Bian Z.

Br J Oral Maxillofac Surg. 2006 Aug;44(4):322-4. Epub 2005 Nov 28.

PMID:
16310907
13.

Craniofacial anomalies: from development to molecular pathogenesis.

Rice DP.

Curr Mol Med. 2005 Nov;5(7):699-722. Review.

PMID:
16305494
14.

Aggressive behaviour of cherubism in a teenager: 4-years of clinical follow-up associated with radiographic and histological features.

Gomes MF, de Souza Setúbal Destro MF, de Freitas Banzi EC, dos Santos SH, Claro FA, de Oliveira Nogueira T.

Dentomaxillofac Radiol. 2005 Sep;34(5):313-8.

PMID:
16120883
15.

Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings.

Martínez-Tello FJ, Manjón-Luengo P, Martin-Pérez M, Montes-Moreno S.

Skeletal Radiol. 2005 Dec;34(12):793-8. Epub 2005 Aug 11.

PMID:
16096755
16.

Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism.

Jafarov T, Ferimazova N, Reichenberger E.

Clin Genet. 2005 Aug;68(2):190-1. No abstract available.

PMID:
15996221
17.

Clinical and radiological features of central giant-cell lesions of the jaw.

De Lange J, Van den Akker HP.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Apr;99(4):464-70.

PMID:
15772595
18.

Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome.

Lee JS, Tartaglia M, Gelb BD, Fridrich K, Sachs S, Stratakis CA, Muenke M, Robey PG, Collins MT, Slavotinek A.

J Med Genet. 2005 Feb;42(2):e11. No abstract available.

19.

The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.

Foucault I, Le Bras S, Charvet C, Moon C, Altman A, Deckert M.

Blood. 2005 Feb 1;105(3):1106-13. Epub 2004 Sep 2.

20.

Giant cell reparative granuloma of the orbit associated with cherubism.

Font RL, Blanco G, Soparkar CN, Patrinely JR, Ostrowski ML.

Ophthalmology. 2003 Sep;110(9):1846-9.

PMID:
13129888
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk